Healthcare Leaders Address Economic, Regulatory, and Sustainability Challenges Ahead of AHRMM25
DENVER, CO / ACCESS Newswire / August 3, 2025 / With global economic volatility, workforce dislocation, and intensifying regulatory mandates, U.S. healthcare organizations are under mounting pressure to modernize their supply chain and materials management systems. Black Book Research's latest report, timed ahead of AHRMM25, provides a comprehensive snapshot of how providers are responding to these challenges and identifies the strategic KPIs guiding 2025 vendor evaluations.
Survey Overview and Participation
Black Book Research conducted its 12th Annual Healthcare Supply Chain and Purchasing Technology Survey from Q3 2024 to Q2 2025. The survey collected validated responses from 1,744 participants representing 1,036 unique healthcare delivery organizations.
Participating Organization Types: 648 hospitals and integrated delivery networks (IDNs); 218 physician organizations; 168 outpatient and ambulatory surgery centers; 108 diagnostic, imaging, and therapy centers; 94 long-term, post-acute, and home health facilities;
Roles of Respondents Included: Chief Supply Chain Officers (CSCOs); Procurement and contracting specialists; CFOs and senior finance executives
IT directors and analysts; Clinical operations and nursing leaders; and OR and Pharmacy logistics managers.
Key Findings and Market Shifts
1. Financial Disruption Accelerates Tech Modernization
81% of hospitals revised 2025-2026 capital budgets to include new supply chain technologies. Shrinking margins, exacerbated by price volatility and labor inefficiencies, are driving urgent investments in automation, cloud-based inventory tools, and real-time visibility platforms.
2. Global Unrest Spurs Domestic Reshoring
53% of respondents reported shifting toward U.S.-based sourcing and distribution solutions. Institutions with international vendor dependency cited tariff hikes, customs delays, and export restrictions as key risk factors.
3. Sustainability, DEI, and Ethical Procurement on the Rise
62% of systems now require vendors to meet environmental and social responsibility benchmarks. Transparency in packaging, ethical sourcing, and supplier DEI certifications were highlighted as minimum expectations by 71% of executives despite presidential policy shifts occurring.
4. Staffing Shortages Delay Technology Implementation
45% of hospitals reported deferring planned IT upgrades due to technical staffing constraints. 26% indicated difficulty in operationalizing AI-powered procurement and inventory systems, especially in rural markets.
5. Regulatory Requirements Reshape Platform Requirements
New CMS mandates and FDA traceability laws are driving demand for platforms with audit-readiness, unit-level tracking, and interoperability with clinical systems. 81% of finance leaders expect increased compliance scrutiny in 2026 and beyond.
Why These 18 KPIs Are Considered Definitive for Supply Chain Technology EvaluationBlack Book Research's 18 qualitative key performance indicators were developed over a decade of collaboration with healthcare professionals to reflect the full lifecycle of supply chain system value-from pre-deployment strategy to post-implementation ROI and support. These KPIs balance strategic, operational, and user experience dimensions to deliver a holistic measure of vendor effectiveness.
Each KPI represents a critical component of healthcare supply chain performance:
Strategic Alignment with Client Goals - Measures how well the vendor aligns with initiatives like ONC certification, value-based care, and financial outcomes.
Innovation and Technology Advancement - Rates forward-thinking capabilities including AI, IoT, blockchain, and machine learning applications.
System Customization & Flexibility - Evaluates adaptability to different facility types, user roles, and procurement strategies.
Ease of Integration with Existing Infrastructure - Focuses on interoperability with EHRs, ERP, pharmacy systems, and other HIT.
User Experience & Interface Design - Measures end-user satisfaction with daily workflows and visual navigation.
Mobile and Remote Accessibility - Reviews mobile application functionality, device-agnostic usability, and offsite management.
Deployment and Implementation Success - Includes go-live timeline accuracy, project management quality, and activation support.
Training, Onboarding, and Knowledge Transfer - Assesses the effectiveness and accessibility of user education.
Scalability Across Sites and Facility Types - Reviews how well systems scale to multi-site IDNs or expanding networks.
System Uptime and Operational Reliability - Evaluates availability, outages, and incident response.
Accuracy of Inventory Data & Real-Time Visibility - Tracks capabilities in live monitoring, demand sensing, and traceability.
Security, Privacy, and Regulatory Compliance - Includes HIPAA, HITECH, FDA, and data encryption standards.
Transparent Cost Models and Predictable Pricing - Measures contract clarity, pricing consistency, and cost forecasting.
Demonstrated Return on Investment (ROI) - Quantifies productivity gains, cost reductions, and clinical outcome improvements.
Fair and Accountable Contracting Terms - Looks at vendor transparency, penalty clauses, and renewal options.
Vendor Support Responsiveness and Help Desk Quality - Assesses resolution speed, 24/7 access, and technical expertise.
Client-Vendor Relationship & Cultural Fit - Qualitatively scores communication, trust, and shared goals.
Overall User and Stakeholder Satisfaction - Aggregates satisfaction across financial, clinical, and IT leadership.
Confidence Level of the Results
Black Book applies a weighted average satisfaction scoring methodology with a 95% confidence level and a margin of error of ±2.7%. The integrity of each survey cycle is independently validated through statistical testing and cross-verification with organizational procurement records.
About Black Book Research
Black Book Research is the healthcare industry's most trusted source for unbiased, crowd-sourced vendor performance ratings and flash polling. Founded by Doug Brown, author of the WSJ bestseller The Black Book of Outsourcing (Wiley Publishers 2009), the firm has surveyed over 3.3 million healthcare professionals globally since 2010. Black Book provides deep, actionable insights to healthcare executives, supply chain teams, and IT leaders evaluating new technologies, with no influence from vendors, sponsors, or consultants. Press Contact :Black Book Research Press Office [email protected] 800-863-7590 www.blackbookmarketresearch.com
Contact InformationPress Office 8008637590
SOURCE: Black Book Research
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect
Global insurance giant MetLife (NYSE:MET) will be reporting results this Wednesday afternoon. Here's what investors should know. MetLife beat analysts' revenue expectations by 3% last quarter, reporting revenues of $18.83 billion, up 10.6% year on year. It was a slower quarter for the company, with a significant miss of analysts' book value per share estimates and a miss of analysts' EPS estimates. Is MetLife a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MetLife's revenue to be flat year on year at $18.64 billion, in line with its flat revenue from the same quarter last year. Adjusted earnings are expected to come in at $2.16 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. MetLife has missed Wall Street's revenue estimates four times over the last two years. Looking at MetLife's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. MetLife is down 5.3% during the same time and is heading into earnings with an average analyst price target of $94.14 (compared to the current share price of $75). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
11 minutes ago
- Yahoo
HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings
Sales and marketing software maker HubSpot (NYSE:HUBS) will be announcing earnings results this Wednesday afternoon. Here's what to look for. HubSpot beat analysts' revenue expectations by 2% last quarter, reporting revenues of $714.1 million, up 15.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts' billings estimates and a solid beat of analysts' EBITDA estimates. It added 10,319 customers to reach a total of 258,258. Is HubSpot a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting HubSpot's revenue to grow 16% year on year to $739.3 million, slowing from the 20.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HubSpot has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 3.1% on average. Looking at HubSpot's peers in the sales and marketing software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Freshworks delivered year-on-year revenue growth of 17.5%, beating analysts' expectations by 2.9%, and BigCommerce reported revenues up 3.2%, topping estimates by 1.3%. Freshworks traded down 2.5% following the results while BigCommerce was up 4.6%. Read our full analysis of Freshworks's results here and BigCommerce's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the sales and marketing software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3% on average over the last month. HubSpot is down 7.8% during the same time and is heading into earnings with an average analyst price target of $736.74 (compared to the current share price of $512.20). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Primerica Earnings: What To Look For From PRI
Financial services company Primerica (NYSE:PRI) will be reporting results this Wednesday after market hours. Here's what to expect. Primerica beat analysts' revenue expectations by 2.1% last quarter, reporting revenues of $803.6 million, up 9.4% year on year. It was a mixed quarter for the company, with net premiums earned in line with analysts' estimates but a slight miss of analysts' book value per share estimates. Is Primerica a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Primerica's revenue to grow 6.1% year on year to $786.1 million, slowing from the 9.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $5.20 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Primerica has missed Wall Street's revenue estimates four times over the last two years. Looking at Primerica's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. Primerica is down 2.8% during the same time and is heading into earnings with an average analyst price target of $307.29 (compared to the current share price of $265.39). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
